Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Plavix Is Expected to Launch in Germany In Mid-August

Executive Summary

The two companies with rights to market a generic version of Plavix (clopidogrel) in Germany are mum about their launch date. But Sanofi-Aventis, which markets Plavix with Bristol-Myers Squibb, does not expect to see generic products on the German market before mid-August

You may also be interested in...



Plavix ruling upheld

U.S. Court of Appeals for the Federal District has upheld the district court ruling that the Plavix (clopidogrel) patent is valid and enforceable, maintaining protection until November 2011 (1"The Pink Sheet" Aug. 4, 2008, p. 19). Sanofi-Aventis and Bristol-Myers Squibb are seeking damages from Apotex, which launched a generic for part of 2006

Plavix ruling upheld

U.S. Court of Appeals for the Federal District has upheld the district court ruling that the Plavix (clopidogrel) patent is valid and enforceable, maintaining protection until November 2011 (1"The Pink Sheet" Aug. 4, 2008, p. 19). Sanofi-Aventis and Bristol-Myers Squibb are seeking damages from Apotex, which launched a generic for part of 2006

Apotex Seeks To Maintain 156 Days Of Exclusivity For Generic Plavix

Apotex petitions FDA to stay action on other clopidogrel ANDAs, as Dr. Reddy’s gets into position for a generic launch.

UsernamePublicRestriction

Register

ID1130765

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel